Literature DB >> 28551302

Acute stroke differential diagnosis: Stroke mimics.

Pedro Vilela1.   

Abstract

Stroke mimics (SM) are non-vascular conditions that present with an acute neurological deficit simulating acute ischemic stroke and represent a significant percentage of all acute stroke hospital admissions. The most common clinical SM includes conversion/functional (psychiatric disorder); seizures and postictal paralysis; toxic-metabolic disturbances; brain tumours; infections, and migraine. Imaging is essential for SM recognition, being Diffusion weighted imaging (DWI), perfusion imaging and angiographic studies very useful. There are several disorders that may have imaging features that simulate acute ischemic stroke, mainly presenting with cytotoxic oedema and/or perfusion deficits. The imaging features of the most frequent clinical and imaging stroke mimics are reviewed.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute ischemic stroke; Migraine; Posterior Reversible Encephalopathy Syndrome PRES; Reversible Cerebral Vasoconstriction Syndrome RCVS; Seizures; Stroke mimic; Transient periictal MRI abnormalities TPMA

Mesh:

Year:  2017        PMID: 28551302     DOI: 10.1016/j.ejrad.2017.05.008

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  15 in total

1.  Stroke Mimics in the Acute Setting: Role of Multimodal CT Protocol.

Authors:  E Prodi; L Danieli; C Manno; A Pagnamenta; E Pravatà; L Roccatagliata; C Städler; C W Cereda; A Cianfoni
Journal:  AJNR Am J Neuroradiol       Date:  2021-12-30       Impact factor: 3.825

2.  Abdominal aortic aneurysm rupture presenting with focal weakness and altered mental status: a case report.

Authors:  Brigid M Garrity; Eric Sugarman; Stephen Pulley
Journal:  Int J Emerg Med       Date:  2022-06-22

3.  Posterior Reversible Encephalopathy Syndrome Following Chemotherapy and Immune Checkpoint Inhibitor Combination in a Patient with Small-Cell Lung Cancer.

Authors:  Cécile Evin; Nathalie Lassau; Corinne Balleyguier; Tarek Assi; Samy Ammari
Journal:  Diagnostics (Basel)       Date:  2022-06-02

Review 4.  [Fast MRI sequences for clarification of acute neurological symptoms].

Authors:  K J Wenger; E Hattingen
Journal:  Radiologe       Date:  2020-03       Impact factor: 0.635

5.  European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke.

Authors:  Eivind Berge; William Whiteley; Heinrich Audebert; Gian Marco De Marchis; Ana Catarina Fonseca; Chiara Padiglioni; Natalia Pérez de la Ossa; Daniel Strbian; Georgios Tsivgoulis; Guillaume Turc
Journal:  Eur Stroke J       Date:  2021-02-19

6.  Community perceptions on the role of sexual activity on stroke: a qualitative study exploring the views of Ghanaian local community residents.

Authors:  Olutobi Adekunle Sanuade
Journal:  BMC Public Health       Date:  2019-06-10       Impact factor: 3.295

Review 7.  Clinical features, pathogenesis, and management of stroke-like episodes due to MELAS.

Authors:  Syuichi Tetsuka; Tomoko Ogawa; Ritsuo Hashimoto; Hiroyuki Kato
Journal:  Metab Brain Dis       Date:  2021-06-12       Impact factor: 3.584

8.  Development and Validation of a LASSO Prediction Model for Better Identification of Ischemic Stroke: A Case-Control Study in China.

Authors:  Zirui Meng; Minjin Wang; Shuo Guo; Yanbing Zhou; Mingxue Zheng; Miaonan Liu; Yongyu Chen; Zhumiao Yang; Bi Zhao; Binwu Ying
Journal:  Front Aging Neurosci       Date:  2021-07-08       Impact factor: 5.750

9.  Association between sleep duration and stroke prevalence in Korean adults: a cross-sectional study.

Authors:  Min-Young Kim; Seunghoon Lee; You Ho Myong; Yoon Jae Lee; Me-Riong Kim; Joon-Shik Shin; Jinho Lee; In-Hyuk Ha
Journal:  BMJ Open       Date:  2018-06-14       Impact factor: 2.692

10.  Acute visual impairment as a main presenting symptom of non-convulsive status epilepticus: a case report.

Authors:  Yi Yang; Shunyuan Zhang; Jinfeng Duan; Xianwen Zhang; Yufeng Tang
Journal:  BMC Neurol       Date:  2020-02-11       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.